Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Moclobemide 150mg tablets
0403020K0AAAAAA
|
Moclobemide | Moclobemide | Central Nervous System | 1,482 |
|
Moclobemide 300mg tablets
0403020K0AAACAC
|
Moclobemide | Moclobemide | Central Nervous System | 1,159 |
|
Manerix 150mg tablets
0403020K0BBAAAA
|
Manerix | Moclobemide | Central Nervous System | 171 |
|
Manerix 300mg tablets
0403020K0BBABAC
|
Manerix | Moclobemide | Central Nervous System | 143 |
|
Moclobemide 150mg/5ml oral suspension
0403020K0AAADAD
|
Moclobemide | Moclobemide | Central Nervous System | No data available |
|
Moclobemide 50mg/5ml oral suspension
0403020K0AAAEAE
|
Moclobemide | Moclobemide | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.